Search | The Journal of the American Osteopathic Association

Sort View

Showing 1 – 5 of 5

SORT: Best Match Most Recent

VIEW: Basic | Expanded

Articles January 01, 2012

Initiating a Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes Mellitus

PDF

James R. Gavin, III, MD, PhD
TOPICS: agonists, diabetes mellitus, type 2, glucagon-like peptide 1
The Journal of the American Osteopathic Association, January 2012, Vol. 112, S16-S21. doi:

Articles January 01, 2012

Common Patient Concerns About the Use of Glucagon-like Peptide-1 Receptor Agonists in Diabetes Mellitus Management

PDF

Jeffrey S. Freeman, DO; James R. Gavin, III, MD, PhD; Craig W. Spellman, DO, PhD
TOPICS: agonists, diabetes mellitus, glucagon-like peptide 1
The Journal of the American Osteopathic Association, January 2012, Vol. 112, S22-S24. doi:

Articles May 01, 2011

Type 2 Diabetes Mellitus: Practical Approaches for Primary Care Physicians

PDF

James R. Gavin, III, MD, PhD; Jeffrey S. Freeman, DO; Jay H. Shubrook, Jr, DO; Frank Lavernia, MD
TOPICS: diabetes mellitus, type 2, metformin
The Journal of the American Osteopathic Association, May 2011, Vol. 111, S3-S12. doi:

Articles May 01, 2010

Improving Outcomes in Patients With Type 2 Diabetes Mellitus: Practical Solutions for Clinical Challenges

PDF

James R. Gavin, III, MD, PhD; Mark W. Stolar, MD; Jeffrey S. Freeman, DO; Craig W. Spellman, DO, PhD
TOPICS: diabetes mellitus, type 2, glucose control, hemoglobin a, glycosylated
The Journal of the American Osteopathic Association, May 2010, Vol. 110, S2-S14. doi:

Articles May 01, 2008

Reducing Global Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

PDF

James R. Gavin, III, MD, PhD
TOPICS: diabetes mellitus, type 2, cardiovascular disease risk factors, hemoglobin a, glycosylated, dipeptidyl-peptidase iv inhibitors
The Journal of the American Osteopathic Association, May 2008, Vol. 108, S14-S19. doi: